Morning glory sign: A particular MR finding in progressive supranuclear palsy

Magnetic Resonance in Medical Sciences

Volumn 3, Issue 3, 2004, Pages 125-132

  Adachi, Michito ^a   Kawanami, Toru ^b   Ohshima, Humi ^a   Sugai, Yukio ^b   Hosoya, Takaaki ^b  

^a Ohshima Clinic   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Brain; Magnetic resonance imaging; Parkinsonian syndrome; Progressive supranuclear palsy

Indexed keywords

AGED; ARTICLE; ATROPHY; FEMALE; HUMAN; MALE; MESENCEPHALON; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; RETROSPECTIVE STUDY;

AGED; ATROPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; MIDDLE AGED; RETROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 24344436825     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.3.125     Document Type: Article

References (28)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184.
2. Nath U, Ben-Shlomo Y, Thomson RG, et al. Clinical features of progressive supranuclear palsy (PSP) in the United Kingdom. Neurology 2001; 56 (supple 3):A458.
3. Schrag A, Ben-Sclomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999; 354:1771-1775.
4. Nath U, Ben-Shlomo Y, Thomson RG, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001; 124:1438-1449.
5. Schrag A, Good CD, Miszkirl K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54:697-702.
6. Asato R, Akiguchi I, Masunaga S, Hashimoto N. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. J Neural Transm 2000; 107:1427-1436.
7. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple accurate method of differentiating between Parkinson disease and supranuclear palsy. Arch Neurol 2001; 58:1076-1079.
8. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47:1-9.
9. Braffman BH, Drossman RI, Goldberg HI, et al. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. AJNR 1988; 9:1093-1099.
10. Duguid JR, DeLaPaz R, DeGroot HI: Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986; 20:744.
11. Pujol J, Junque C, Vendrell P, Grau JM, Capudevila A. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch Neurol 1992; 49:1119-1122.
12. Huber SJ, Chakeres DW, Paulson GW, Khanna R. Magnetic resonance imaging in Parkinson's disease. Arch Neurol 1990; 47:735-737.
13. Doraiswamy PM, Shah SA, Husain MM, et al. Magnetic resonance evaluation of the midbrain in Parkinson's disease. Arch Neurol 1991; 48:360.
14. Antonini A, Leenders KL, Meier D, Oertel WH, Boesiger P, Anliker M. T2 relaxation time in patients with Parkinson's disease. Neurology 1993; 43:697-700.
15. Gorell JM, Ordidge RJ, Brown GG, Deniau MS, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995; 45:1138-1143.
16. Stern MB, Braffmann BH, Skolnick BE, Hrutig HI, Grossman RI. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndrome. Neurology 1989; 39:1524-1526.
17. Adachi M, Hosoya T, Haku T, Yamaguchi K, Kawanami T. Evaluation of the substantia nigra in patients with parkinsonian syndrome accomplished using multishot diffusion weighted MR imaging. AJNR 1999; 20:1500-1506.
18. Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion-recovery MR findings. AJNR 2002; 23:1747-1756.
19. Drayer BT, Olanow W, Burger P, et al. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986; 159:493-498.
20. Sarvoiardo M, Strada L, Girotti F, et al. MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 1989; 13:555-560.
21. Pastakia B, Polinsky R, Di Chiro G, et al. Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology 1986; 159:499-502.
22. Naka H, Ohshita T, Murata Y, Imon Y, Mimori Y, Nakamura S. Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 2002; 44:204-209.
23. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurology 2002; 1: 359-369
24. Hauw JJ, Daniel SE, Dickson SE, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-2019.
25. Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. Oxford: Oxford University Press, 1992; 44-88.
26. Jellinger KA. Neuropathological findings in multiple system atrophy with dystonia. J Neurol Neurosurg Psychiatr 2002; 73:460-461.
27. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12:133-147.
28. Righini A, Antonini A, Notaris RD, et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR 2004; 25:927-932.